ReviewFrontiers in immunology2025

Beyond inflammation: the multifaceted therapeutic potential of targeting the CXCL8-CXCR1/2 axis in type 1 diabetes.

Georgia Fousteri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.